Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.65 USD | -3.55% | -0.48% | -24.94% |
Financials (USD)
Sales 2024 * | 406M | Sales 2025 * | 448M | Capitalization | 1.58B |
---|---|---|---|---|---|
Net income 2024 * | -4M | Net income 2025 * | 9M | EV / Sales 2024 * | 3.34 x |
Net cash position 2024 * | 226M | Net cash position 2025 * | 291M | EV / Sales 2025 * | 2.87 x |
P/E ratio 2024 * |
-400
x | P/E ratio 2025 * |
182
x | Employees | 815 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.22% |
Latest transcript on Veracyte, Inc.
1 day | -3.55% | ||
1 week | -0.48% | ||
Current month | -0.48% | ||
1 month | +0.10% | ||
3 months | -9.11% | ||
6 months | -19.40% | ||
Current year | -24.94% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Stapley
CEO | Chief Executive Officer | 54 | 21-05-31 |
Rebecca Chambers
DFI | Director of Finance/CFO | 46 | 21-07-18 |
Steven French
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Evan Jones
BRD | Director/Board Member | 67 | 08-01-31 |
Robert Epstein
CHM | Chairman | 58 | 15-01-11 |
Karin Eastham
BRD | Director/Board Member | 74 | 12-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 20.65 | -3.55% | 470,343 |
24-06-06 | 21.41 | -1.83% | 522,827 |
24-06-05 | 21.81 | +2.44% | 573,763 |
24-06-04 | 21.29 | +0.66% | 478,267 |
24-06-03 | 21.15 | +1.93% | 613,217 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.94% | 1.58B | |
-41.97% | 7.92B | |
+5.99% | 3.51B | |
-4.31% | 2.18B | |
-21.69% | 1.97B | |
+31.45% | 1.14B | |
+26.75% | 792M | |
-9.83% | 690M | |
-26.33% | 532M | |
+3.38% | 303M |
- Stock Market
- Equities
- VCYT Stock